Recent News

Altaris Acquires Padagis from Perrigo

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has completed the acquisition of Padagis LLC (“Padagis”), formerly the generic prescription pharmaceuticals business of Perrigo Company plc (NYSE; TASE: PRGO), for total consideration equal…

Altaris Appoints Tim Callahan, Shawn Cavanagh and Rafael Torres as Operating Partners

New York, NY–Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) is pleased to announce the appointment of Tim Callahan, Shawn Cavanagh and Rafael Torres as Operating Partners. Messrs. Callahan, Cavanagh and Torres bring a broad range of experience across…

Altaris Announces Sale of Paramit

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has entered into an agreement to sell Paramit Corporation (“Paramit”) to The Tecan Group (SIX Swiss Exchange: TECN) for a total consideration of $1.0 billion….

Altaris Completes Partnership with Michelin and Acquires Majority Stake in Solesis

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has completed the acquisition of a 51% stake in Solesis LLC (“Solesis”) from Michelin. As part of the transaction, Michelin retained a 49% stake in Solesis,…

Kindeva Drug Delivery Announces Knowledge Transfer Partnership with Loughborough University to Study Sustainable Propellants

Loughborough, U.K.—Kindeva Drug Delivery L.P. (Kindeva) has announced a Knowledge Transfer Partnership (KTP) with Loughborough University to develop more sustainable alternative propellants for inhaled drug products. The KTP is jointly funded by Kindeva and UKRI (United Kingdom Research and Innovation)…

Trean Insurance Group Prices Secondary Offering of Common Stock

Wayzata, MN—(GLOBE NEWSWIRE)—Trean Insurance Group, Inc. (Nasdaq:TIG) (“Trean”) today announced the pricing of a secondary offering of 5,000,000 shares of Trean common stock at a price of $14.00 per share. The offering is expected to close on May 24, 2021,…

Minnetronix Medical Receives Minnesota Manufacturing Award from Business Journal

Minneapolis, MN—Minnetronix Medical, Inc., was honored by the Minneapolis St. Paul Business Journal with a 2021 Minnesota Manufacturing Award for Product Innovation for the Minnetronix MindsEye™ Expandable Port. Minnetronix partners with medical device companies to develop products from design through…

Minnetronix Medical Recognized for Surgical Technology Innovation in 2021 MedTech Breakthrough Awards Program

St. Paul, MN—Minnetronix Medical, Inc., a leading medical technology partner to global medical device companies, today announced that its MindsEye™ Expandable Port has won the “Best New Technology Solution – Surgical” award in the fifth annual MedTech Breakthrough Awards program….

Participation in SilverSneakers Leads to a Substantial Decrease in Overall Healthcare Costs and Improved Health Outcomes for Seniors

Nashville, TN—PRNewswire—Total average healthcare expenses are significantly reduced by 16% for SilverSneakers® participants compared to non-participating Medicare Advantage members, according to a new comprehensive scientific study. The study was conducted by well-respected healthcare consulting firm Avalere Health and released today…

Altaris to Partner with Michelin and Acquire Majority Stake in Solesis

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has entered into an agreement with Michelin to acquire a 51% stake of Solesis, Inc. (“Solesis”). Following closing of the transaction, Michelin will retain a…

Kindeva Appoints Greg Sargen to Board of Directors

St. Paul, MN—Kindeva Drug Delivery L.P. (Kindeva) announced that Greg Sargen has joined Kindeva’s Board of Directors. The appointment of Mr. Sargen is effective as of April 5, 2021. Mr. Sargen, with over 20 years of experience in the biopharmaceutical…

Kindeva Drug Delivery and Cambridge Healthcare Innovations Limited to Collaborate on Development of Novel Dry-Powder Inhaler Product

St. Paul, MN—Kindeva Drug Delivery L.P. (Kindeva) and Cambridge Healthcare Innovations Limited (CHI) have entered into a collaboration to develop and commercialize CHI’s αeolus dry-powder inhaler (DPI) platform technology. The collaboration will leverage Kindeva’s product development, regulatory affairs, and manufacturing…